• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

Eisai

liver
Posted inOncology, Research

Tecentriq Plus Avastin: Most Effective Treatment for Unresectable Hepatocellular Carcinoma

January 30, 2022September 8, 2022

Atezolizumab with bevacizumab: a powerful immunotherapy approach for first-line therapy of liver cancer.

brain
Posted inClinical Trials, Neuroscience

Buntanetap: Breakthrough in Treatment of Alzheimer’s and Parkinson’s

January 11, 2022September 8, 2022

Buntanetap acts simultaneously on three neurotoxic proteins responsible for neurodegenerative disorders: amyloid beta, alpha-synuclein, and tau protein.

insomnia
Posted inNeuroscience, New Drugs, Regulatory

Quviviq: New Sleeping Pill

January 10, 2022November 5, 2022

Daridorexant will help treat insomnia.

Insomnia.
Posted inNeuroscience, New Drugs, Regulatory

Dayvigo: New Japanese Drug for Insomnia

April 4, 2021September 8, 2022

Lemborexant by Eisai to help you fall asleep. Chronic sleep loss, go away!

BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2023 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News